492 related articles for article (PubMed ID: 7160398)
1. Clinical application of inotropic drugs.
Counihan TB
Eur Heart J; 1982 Dec; 3 Suppl D():143-7. PubMed ID: 7160398
[No Abstract] [Full Text] [Related]
2. The future of inotropic drugs in clinical practice.
Smith TW
Eur Heart J; 1982 Dec; 3 Suppl D():149-56. PubMed ID: 6130948
[No Abstract] [Full Text] [Related]
3. Digitalis in cardiac failure. Do benefits justify risks?
Selzer A
Arch Intern Med; 1981 Jan; 141(1):18-9. PubMed ID: 7447579
[No Abstract] [Full Text] [Related]
4. Inotropic drugs for treatment of the failing heart.
Maskin CS; Le Jemtel TH; Sonnenblick EH
Cardiovasc Clin; 1984; 14(3):1-17. PubMed ID: 6327040
[No Abstract] [Full Text] [Related]
5. The role of digitalis in the treatment of heart failure.
Demers C; McKelvie RS; Yusuf S
Coron Artery Dis; 1999 Sep; 10(6):353-60. PubMed ID: 10474784
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of circulatory diseases: recent progress. 3. Heart failure].
Kusukawa R
Nihon Naika Gakkai Zasshi; 1986 Jul; 75(7):866-72. PubMed ID: 3782992
[No Abstract] [Full Text] [Related]
7. Clinical and circulatory aspects of digitalis in heart failure.
Storstein L
Eur Heart J; 1982 Dec; 3 Suppl D():59-64. PubMed ID: 6761128
[No Abstract] [Full Text] [Related]
8. Inotropic drugs in the management of congestive heart failure.
Skelton CL
J La State Med Soc; 1979 Apr; 131(4):109-17. PubMed ID: 458229
[No Abstract] [Full Text] [Related]
9. [The importance of cardiac glycoside therapy. Digitalis--to use or not to use?].
Jerie P
Ther Umsch; 1984 Feb; 41(2):96-102. PubMed ID: 6369617
[No Abstract] [Full Text] [Related]
10. [Positive inotropic agents in the treatment of congestive heart failure].
Hori M; Tamai J; Inoue M
Kokyu To Junkan; 1987 Mar; 35(3):261-7. PubMed ID: 3296067
[No Abstract] [Full Text] [Related]
11. [Inotropic agents: why yes and why not].
Ferrari M; Magnolfi G; Piovan D; Bertagna E
Cardiologia; 1996 Sep; 41(9):831-41. PubMed ID: 8983841
[No Abstract] [Full Text] [Related]
12. [Digitalis in heart failure--still a therapeutic principle of current interest?].
Manhenke CA; Dickstein K
Tidsskr Nor Laegeforen; 2001 Jan; 121(2):212-4. PubMed ID: 11475203
[No Abstract] [Full Text] [Related]
13. [Positive inotropic agents in heart failure. Clinico-pharmacological evidence for medical practice].
Rohde LE; Ribeiro JP
Arq Bras Cardiol; 1994 Dec; 63(6):537-42. PubMed ID: 7605243
[No Abstract] [Full Text] [Related]
14. [Pharmacologic basis of cardiotonic glucoside therapy].
Imbs JL
Cardiology; 1980; 65 Suppl 1():1-8. PubMed ID: 7379062
[No Abstract] [Full Text] [Related]
15. [Are cardiac glycosides still needed in the treatment of cardiac insufficiency?].
Böhm M
Dtsch Med Wochenschr; 2002 Oct; 127(41):2133-8. PubMed ID: 12397560
[No Abstract] [Full Text] [Related]
16. Cardiac glycosides, digoxin toxicity, and the antidote.
Felicilda-Reynaldo RF
Medsurg Nurs; 2013; 22(4):258-61. PubMed ID: 24147325
[No Abstract] [Full Text] [Related]
17. Cardiac glycosides in the next millennium.
Hauptman PJ; Garg R; Kelly RA
Prog Cardiovasc Dis; 1999; 41(4):247-54. PubMed ID: 10362347
[TBL] [Abstract][Full Text] [Related]
18. [Modern evaluations of the activity of inotropic agents].
Dalla Volta S
G Ital Cardiol; 1986 Mar; 16(3):250-1. PubMed ID: 2942435
[No Abstract] [Full Text] [Related]
19. [Digitalis and sinus rhythm. An old question that is still current].
Bobbio M
G Ital Cardiol; 1986 Mar; 16(3):241-9. PubMed ID: 3525303
[TBL] [Abstract][Full Text] [Related]
20. Special concerns of digitalis use in elderly patients.
Roffman DS
Geriatrics; 1984 Jun; 39(6):97-8, 103-5. PubMed ID: 6724308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
